Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.280
+0.020 (1.59%)
Mar 26, 2026, 4:00 PM EDT - Market closed

Treace Medical Concepts Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10.7111.3512.9819.47105.83
Short-Term Investments
37.6664.33110.2261.78-
Cash & Short-Term Investments
48.3775.68123.281.25105.83
Cash Growth
-36.09%-38.57%51.63%-23.23%485.39%
Accounts Receivable
42.1640.838.0629.218.57
Inventory
36.0339.2629.2519.3310.56
Other Current Assets
5.55.677.853.623.01
Total Current Assets
132.05161.4198.36133.4137.97
Net Property, Plant & Equipment
37.3734.431.5625.482.85
Other Intangible Assets
7.138.089.03--
Goodwill
12.8212.8212.82--
Other Long-Term Assets
1.220.410.150.15-
Total Assets
190.58217.09251.91159.02140.82
Accounts Payable
6.7310.5211.848.674.06
Accrued Expenses
21.4823.8928.7721.2414.15
Other Current Liabilities
2.430.514.430.34-
Total Current Liabilities
30.6434.9345.0330.2518.21
Long-Term Debt
55.5853.3153.0152.7129.37
Long-Term Leases
13.9815.9315.8915.54-
Other Long-Term Liabilities
3.050.040.04-0.17
Total Long-Term Liabilities
72.6169.2868.9468.2529.54
Total Liabilities
103.25104.2113.9798.547.75
Common Stock
0.060.060.060.060.05
Treasury Stock
-1.18-0.28-0.01--
Additional Paid-in Capital
337.37303271.97145.22134.93
Accumulated Other Comprehensive Income
0.070.10.16-0.03-
Retained Earnings
-248.99-189.99-134.25-84.72-41.91
Shareholders' Equity
87.33112.89137.9460.5393.07
Total Liabilities & Equity
190.58217.09251.91159.02140.82
Total Debt
69.5769.2468.968.2529.37
Net Cash (Debt)
-21.26.4454.31376.47
Net Cash Growth
--88.14%317.62%-83.00%-
Net Cash Per Share
-0.340.100.890.231.58
Book Value
87.33112.89137.9460.5393.07
Book Value Per Share
1.381.822.271.101.92
Tangible Book Value
67.3992116.160.5393.07
Tangible Book Value Per Share
1.071.481.911.101.92
Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q